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Introduction {#s1}
============

Tetralogy of fallot (TOF) is the most common cyanotic heart lesion beyond the neonatal period^[@R1]^ and it accounts for a third of all congenital heart disease in patients less than 15 years of age.^[@R2]^ It occurs in 10% of all congenital heart disease.^[@R3]^ The prevalence of TOF is approximately 3.9 per 10 000 live births in the United States^[@R4]^ and 10%-26.2% of all congenital heart diseases in Nigeria.^[@R4]-[@R11]^

Diagnosis of TOF is confirmed with echocardiography.^[@R3]^ Definitive diagnostic features and other associated cardiac abnormalities can be identified. In advanced countries, diagnosis can be made in as early as 12 weeks of gestation with fetal echocardiopgraphy.^[@R12],[@R13]^

Management is both medical and surgical and depends on the degree and type of right ventricular outflow tract obstruction and the centre's protocol.^[@R3]^ There is a dearth of literature on TOF in children in Sub-Saharan Africa. This study aim to describe the prevalence, clinical profile and associated cardiac anomaly of children diagnosed with TOF documented over an eight year period in a tertiary hospital in South Western Nigeria.

Materials and Methods {#s2}
=====================

Prospective and cross-sectional, involving all cases of TOF diagnosed with echocardiography at the Lagos State University Teaching Hospital,( LASUTH) between January 2007 and December 2014. The center is a tertiary hospital in South Western Nigeria. The Hospital receives referral from the South Western region and is the largest center that admits pediatric cases.

A pediatric cardiologists reviewed all the subjects referred for evaluation. A GE Vivid Q echocardiography machine with reference number 14502 WP SN 2084 with appropriate sized probes was used throughout the study period and the pediatric cardiologists performed the echocardiography on all the study subjects. Definitive diagnosis of TOF was made with echocardiography.^[@R3]^

The data were analyzed using SPSS version 20. The prevalence of TOF was calculated from all children who presented in the hospital as in-patient and out-patient during the study period. The prevalence of TOF was also calculated amongst those with congenital heart lesions and those with cyanotic congenital heart disease. Tables and charts were used to depict those variables. Descriptive statistic are presented as percentages or means and standard deviation. Means of normally distributed variables were compared using the student *t*-test and proportions using chi-square test. Skewed distribution were analyzed using appropriate non-parametric tests. Level of significance set at *P *\< 0.05

Results {#s3}
=======

Prevalence of Tetralogy of Fallot {#s3-1}
---------------------------------

A total of 155 patients with echo diagnosis of TOF were documented between January 2007 and December 2014 with a total of 315 150 patients seen as out-patient and in-patient at the study centre during the study period hence the prevalence of TOF amongst the children who were seen in the hospital during the study period was 4.9 per 10 000. A total of 983 had congenital heart disease while 311 of the 983 patient with congenital heart disease had cyanotic congenital heart disease therefore, TOF accounted for 15.8% and 49.8% of congenital heart disease and cyanotic congenital heart disease respectively. [Table 1](#T1){ref-type="table"} depicts the prevalence of TOF in the study subjects. [Table 2](#T2){ref-type="table"} illustrates the prevalence of TOF in other countries.

###### Yearly Prevalence of TOF at the Study Center

  ---------- ------------- -------------- ------------- --------------------- ----------------------
  **Year**   **CHD (n)**   **CCHD (n)**   **TOF (n)**   **% of TOF in CHD**   **% of TOF in CCHD**
  2007       87            22             13            14.9                  59.1
  2008       119           29             10            8.4                   34.5
  2009       90            23             18            20                    86.9
  2010       103           36             12            11.6                  33.3
  2011       153           48             27            17.6                  56.3
  2012       143           47             26            18.2                  55.3
  2013       180           65             27            33.7                  41.5
  2014       108           41             12            11.1                  29.3
  Total      983           311            155           15.8                  49.8
  ---------- ------------- -------------- ------------- --------------------- ----------------------

Abbreviations‏: CHD, congenital heart disease; CCHD, cyanotic congenital heart disease; TOF; tetralogy of Fallot.

###### Country Prevalence of TOF in CHD

  ------------------ ---------------------------- -------------- -----------------
  **City/Country**   **Author**                   **Year** ^a^   **Percent** ^b^
  Malawi             Kennedy and Miller^[@R14]^   2013           17.9
  Zimbabwe           Bannerman et al^[@R15]^      1998           19.6
  Iran               Rahim et al^[@R16]^          2008           16.9
  Iraq               Khadim and Issa^[@R17]^      2009           12.6
  India              Kapoor and Gupta^[@R18]^     2008           4.6
  Sudan              El Hag^[@R21]^               1994           4.2
  Saudi Arabia       Alabdulgader^[@R22]^         2006           3.5
  Qatar              Robida et al^[@R23]^         1997           5.1
  Denmark            Laursen^[@R24]^              1980           5.8
  Oman               Subramanyan et al^[@R25]^    1998           9.6
  Taiwan             Shann^[@R26]^                1969           18.1
  Canada             Rose et al^[@R27]^           1964           8.1
  ------------------ ---------------------------- -------------- -----------------

Abbreviations‏: CHD, congenital heart disease; TOF; tetralogy of Fallot.

^a^Year of publication‏. ^b^Percentage of TOF in all CHD‏.

Clinical Presentation {#s3-2}
---------------------

The male to female ratio was 1.7:1. The mean age of the children was 51.6 ± 52.5 (months). [Table 3](#T3){ref-type="table"} describes the age groups of the patients. The most common indication for cardiac evaluation in the study subjects was cyanosis with a suspicion of a cyanotic congenital heart disease. 110 (71%) children were clinically cyanosed on presentation. Record of oxygen saturation was documented with pulse oximeter in 89 subjects. 69 of the 89 (77.5%) of the pulse oximeter records had evidence of cyanosis and 63/69 (91%) of the pulse oximeter recordings of cyanosis were truly cyanosed.

###### Age Groups of the Subjectsa

  ------------------------ ---------- ------------ ----------- -------------
  **Age Groups**           **Male**   **Female**   **Total**   **Percent**
  ≤ 6 months^b^            12         8            20          13.8
  \> 6 months -12 months   11         9            20          13.8
  \>12 month-5 years       36         25           61          42.1
  \> 5-10 years            13         1            14          9.6
  Above 10 years           18         12           30          20.7
  Total                    90         55           145         100
  ------------------------ ---------- ------------ ----------- -------------

^a^ The age of four males and five females were missing. The sex and age of one subject was not documented.

^b^ *P* value = 0.17, x^2^= 6.4.

Association Syndromes {#s3-3}
---------------------

However, Down syndrome was documented on 7 subjects, 3 had Turners syndrome and one had CATCH 22. This is shown in [Figure 1](#F1){ref-type="fig"}.
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Discussion {#s4}
==========

The prevalence of TOF in children in the present study is 4.9 per 10 000 children. This prevalence rate is a hospital based result and thus may not represent the prevalence in the general population. Prevalence rate of TOF have been documented in relation to live birth. A prevalence of 3-6 infants per 10 000 live birth have been reported by Bhmji.^[@R2]^ Population prevalence rate is not known in Sub-Saharan Africa.

The general prevalence of TOF amongst all congenital heart disease is 10%.^[@R2],[@R3]^ Different researchers have reported varying rates depending on the region of study. In the present study, TOF was recorded in 15.8% of all congenital heart diseases. Previous studies in Nigeria have documented rates between 10% and 26.2% in all congenital heart diseases.^[@R4]-[@R11]^ Prevalence rate of TOF in all congenital heart diseases in other countries within Africa is between 10 and 19.6%.^[@R14]-[@R16]^ Similarly the authors in Africa had different methods, study subjects, and duration. The prevalence rate in other centers in Iran^[@R17]^ and Iraq^[@R18]^ is 16.9% and 12.6%, respectively which is similar with reports in Africa. In India, different authors have recorded rates between 4.6% and 5.5%.^[@R19],[@R26]^

There was a male predominance of TOF in the present study with a male to female ratio of 1.7:1. This finding is similar with other earlier reports.^[@R18],[@R19],[@R26]^ TOF being a cyanotic congenital heart disease, 71% of our subjects presented with cyanosis. Pulse-oximeter is a vital tool in evaluation of patients with congenital heart disease, we were able to document cyanosis using pulse oximeter in up to 91% of the subjects who were cyanosed. Few patients, 5 (3.2%) presented with atypical presentation like gangrene of the right hand and forearm, stroke, cerebral abscess and congestive cardiac failure. Onset of clinical manifestation in patients with TOF depends on the severity of right ventricular outflow tract obstruction.^[@R3]^ Patients may present in neonatal period when there is severe obstruction to right ventricular outflow. The youngest patient was a 2 days old female who was part of a conjoint twin with TOF and pulmonary atresia. Two-thirds of the patients were under 5 years at diagnosis and 60.4% of those were between 1 and 5 years. One-third of the subjects were more than 5 years at presentation. The mean age of the subjects at presentation was 51.6 ± 52.5 in months (4.3 ± 4.4 in years). This mean age is almost similar to that reported by Kennedy and Miller^[@R14]^ in Malawi. Other authors have presented earlier age at diagnosis of TOF.^[@R26]^ However diagnosis of TOF and other congenital heart diseases are usually made between 1-5 years of age, especially in resource poor countries.^[@R13],[@R18],[@R27]^ Possible reasons for the trend of late presentation and diagnosis includes difficulty in assessing specialized care, poverty and poor health seeking behaviour.^[@R12],[@R13],[@R17]^

Chromosomal anomalies have been documented in up to 25% of patients with TOF, the commonest being trisomies and 22q11.2 micro deletion syndromes.^[@R3]-[@R5]^ We documented in this study 11 (7.1%) patients with TOF and chromosomal anomalies. There were 7 (4.5%) patient with Down syndrome, 3 (1.9%) of Turners syndrome and 1 (0.65%) case of CATCH 22 syndrome. Risk of recurrence rate for TOF is 3%,^[@R3]^ in this study we had two cases of TOF from the same family, a younger and other sibling.

Patients with TOF may have other associated cardiac defects. In this study, we documented the other associated cardiac lesions in our subjects with TOF. The most common was pulmonary atresia followed by atrial septal defect (ASD). All the patients with ASD had secundum ASD.

Conclusion {#s5}
==========

We report a prevalence of 4.9 per 10 000 children in this hospital base study. The prevalence of TOF in congenital heart disease is 15.8% and this was similar to other studies within Nigeria and the sub-region. There was a male predominance and most children presented within 1-5 years of age. Chromosomal abnormalities such as Down syndrome, Turners syndrome and CATCH 22 syndrome were documented in some subjects. Some of the subjects had atypical presentation. TOF is as common in Nigeria as other parts of the world, there is a need to established cardiac centers to salvage these children. Collaboration from developed countries will be helpful in this resource limited region.
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